Edition:
United Kingdom

People: Aimmune Therapeutics Inc (AIMT.OQ)

AIMT.OQ on NASDAQ Stock Exchange Global Select Market

20.32USD
3:51pm BST
Change (% chg)

$-0.08 (-0.39%)
Prev Close
$20.40
Open
$20.40
Day's High
$20.65
Day's Low
$20.07
Volume
38,556
Avg. Vol
216,243
52-wk High
$36.12
52-wk Low
$20.04

Oxtoby, Andrew 

Mr. Andrew Oxtoby is Chief Commercial Officer of the company. Mr. Oxtoby joins Aimmune from Eli Lilly and Company, where he most recently had responsibility for Lilly's U.S. insulin business as Vice President of U.S. Diabetes Connected Care and Insulins, an innovative, patient-focused business unit, after having served as Vice President of U.S. Diabetes Sales. In his more than 16 years with Lilly, Mr. Oxtoby also spent five years in oncology, including as Vice President of the International Oncology business; served as General Manager of Lilly's Netherlands operation; and held positions of increasing responsibility in marketing and sales. Mr. Oxtoby began his career at Procter & Gamble, where he spent four years in the engineering and manufacturing organizations. Mr. Oxtoby holds an M.B.A. from Harvard Business School and a B.S. in mechanical engineering from Purdue University.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --